IQVIA Holdings Inc. logo
IQVIA Holdings Inc. (IQV)
Compare

IQVIA Holdings Inc. (IQV) Free Cash Flow Yield: 8.58%

popular:market cap|pe ratio|revenue|price history|total return

Is IQVIA Holdings Inc.’s free cash flow yield high or low?

IQVIA Holdings Inc.'s free cash flow yield of 8.58% is 69% above its 5-year average of 5.07%, near the high end of its 5-year range (2.92%–9.72%).

The free cash flow yield for IQVIA Holdings Inc. (IQV) is 8.58% as of Wednesday, June 10, 2026. It is above its 12-month average by 17.03% (7.33%).

Free Cash Flow CAGR|Earnings Yield|Dividend Yield|P/FCF Ratio|All Metrics

IQV Free Cash Flow Yield Chart

IQV Free Cash Flow Yield
8.58%+12.45% 1Y
Zoom

IQV Average Free Cash Flow Yield Chart

IQV Current vs Average Free Cash Flow Yield Chart

IQV Free Cash Flow Yield Metrics

FREE CASH FLOW YIELD

8.58%

FREE CASH FLOW YIELD AVG TTM

7.33%

FREE CASH FLOW YIELD AVG 3Y

5.49%

FREE CASH FLOW YIELD AVG 5Y

5.07%

FREE CASH FLOW YIELD AVG 10Y

4.27%

FREE CASH FLOW YIELD AVG 15Y

4.27%

FREE CASH FLOW YIELD AVG 20Y

4.27%

CURRENT VS TTM AVG

+17.03%

CURRENT VS 3Y AVG

+56.27%

CURRENT VS 5Y AVG

+69.23%

CURRENT VS 10Y AVG

+101.08%

CURRENT VS 15Y AVG

+101.15%

CURRENT VS 20Y AVG

+101.15%

IQV Competitors' Free Cash Flow Yield

NAMEMARKET CAPFREE CASH FLOW YIELDTTM3Y5Y
IQVIA Holdings Inc. (IQV)—8.58%7.33%5.49%5.07%
Centene Corporation (CNC)$31.94B19.80%15.16%12.35%12.28%
DexCom, Inc. (DXCM)$29.24B4.80%3.32%2.08%1.41%
Biogen Inc. (BIIB)$29.00B8.99%9.20%6.93%6.70%
Veeva Systems Inc. (VEEV)$27.37B1.86%3.52%3.07%2.74%
Zoetis Inc. (ZTS)$34.20B6.20%4.07%2.90%2.47%
Waters Corporation (WAT)$23.83B0.88%2.83%2.68%2.70%
Agilent Technologies, Inc. (A)$38.26B3.26%3.06%3.54%3.21%
Mettler-Toledo International Inc. (MTD)$22.85B3.46%3.21%3.24%2.88%
BioNTech SE (BNTX)$21.81B6.86%3.80%18.89%19.80%

Yield Comparison

FCF Yield

8.58%

Earnings Yield

4.40%

Dividend Yield

N/A

Formula: FCF Yield = (Free Cash Flow / Market Cap) × 100

How FCF Yield is used:

  • Shows free cash flow after capital expenditures relative to market cap
  • Can be compared with earnings yield and dividend yield
  • Can be compared with the company's historical range
  • Can be compared with peers that report positive free cash flow

FCF vs earnings: Differences between FCF yield and earnings yield can reflect capital expenditures, working capital changes, and other non-cash accounting items.

IQVIA Holdings Inc. Free Cash Flow Yield Formula & Definition

FCF Yield measures free cash flow relative to market capitalization. It compares cash generation after capital expenditures with the equity value of the company.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

IQVIA Holdings Inc. Free Cash Flow Yield FAQ

What is the free cash flow yield for IQVIA Holdings Inc. (IQV)?
The free cash flow yield for IQV stock is 8.58%.
Is IQVIA Holdings Inc.'s free cash flow yield high or low?
IQVIA Holdings Inc.'s free cash flow yield of 8.58% is 69% above its 5-year average of 5.07%, near the high end of its 5-year range (2.92%–9.72%).
What is the TTM average free cash flow yield for IQVIA Holdings Inc. (IQV)?
The TTM average free cash flow yield for IQV stock is 7.33%.
What is the 3Y average free cash flow yield for IQVIA Holdings Inc. (IQV)?
The 3Y average free cash flow yield for IQV stock is 5.49%.
What is the 5Y average free cash flow yield for IQVIA Holdings Inc. (IQV)?
The 5Y average free cash flow yield for IQV stock is 5.07%.
What is the 10Y average free cash flow yield for IQVIA Holdings Inc. (IQV)?
The 10Y average free cash flow yield for IQV stock is 4.27%.
What is the 15Y average free cash flow yield for IQVIA Holdings Inc. (IQV)?
The 15Y average free cash flow yield for IQV stock is 4.27%.
What is the 20Y average free cash flow yield for IQVIA Holdings Inc. (IQV)?
The 20Y average free cash flow yield for IQV stock is 4.27%.

IQVIA Holdings Inc. Free Cash Flow Yield History

DATEFREE CASH FLOW YIELD
2026-06-108.58%
2026-06-098.45%
2026-06-088.57%
2026-06-058.58%
2026-06-048.42%
2026-06-038.64%
2026-06-028.71%
2026-06-018.42%
2026-05-298.64%
2026-05-288.69%
2026-05-279.51%
2026-05-269.72%
2026-05-229.37%
2026-05-219.36%
2026-05-209.17%
2026-05-199.08%
2026-05-189.11%
2026-05-159.30%
2026-05-149.22%
2026-05-139.13%
2026-05-128.99%
2026-05-119.07%
2026-05-088.80%
2026-05-078.81%
2026-05-068.92%
2026-05-058.92%
2026-05-048.96%
2026-05-019.14%
2026-04-309.11%
2026-04-299.21%
2026-04-289.07%
2026-04-278.80%
2026-04-248.89%
2026-04-238.98%
2026-04-228.24%
2026-04-218.21%
2026-04-208.16%
2026-04-178.18%
2026-04-168.39%
2026-04-158.10%
2026-04-148.23%
2026-04-138.39%
2026-04-108.62%
2026-04-098.54%
2026-04-088.36%
2026-04-078.45%
2026-04-068.45%
2026-04-028.33%
2026-04-018.37%
2026-03-318.46%
2026-03-308.68%
2026-03-278.80%
2026-03-268.52%
2026-03-258.71%
2026-03-248.69%
2026-03-238.64%
2026-03-208.69%
2026-03-198.67%
2026-03-188.64%
2026-03-178.57%
2026-03-168.75%
2026-03-138.76%
2026-03-128.86%
2026-03-118.41%
2026-03-108.44%
2026-03-098.08%
2026-03-068.27%
2026-03-058.08%
2026-03-048.11%
2026-03-038.29%
2026-03-028.28%
2026-02-278.07%
2026-02-268.45%
2026-02-258.91%
2026-02-248.75%
2026-02-238.89%
2026-02-208.71%
2026-02-198.52%
2026-02-188.43%
2026-02-178.77%
2026-02-139.21%
2026-02-129.11%
2026-02-118.68%
2026-02-108.42%
2026-02-097.98%
2026-02-068.20%
2026-02-058.50%
2026-02-047.59%
2026-02-037.55%
2026-02-026.65%
2026-01-306.68%
2026-01-296.53%
2026-01-286.41%
2026-01-276.38%
2026-01-266.42%
2026-01-236.54%
2026-01-226.43%
2026-01-216.37%
2026-01-206.58%
2026-01-166.47%
2026-01-156.37%
2026-01-146.37%
2026-01-136.37%
2026-01-126.38%
2026-01-096.34%
2026-01-086.32%
2026-01-076.29%
2026-01-066.39%
2026-01-056.55%
2026-01-026.82%
2025-12-316.82%
2025-12-306.75%
2025-12-296.77%
2025-12-266.78%
2025-12-246.80%
2025-12-236.83%
2025-12-226.85%
2025-12-196.97%
2025-12-186.91%
2025-12-176.94%
2025-12-166.93%
2025-12-156.88%
2025-12-126.92%
2025-12-116.80%
2025-12-106.90%
2025-12-097.05%
2025-12-086.88%
2025-12-056.81%
2025-12-046.84%
2025-12-036.77%
2025-12-026.82%
2025-12-016.73%
2025-11-286.68%
2025-11-266.63%
2025-11-256.63%
2025-11-246.74%
2025-11-216.84%
2025-11-207.08%
2025-11-197.07%
2025-11-187.08%
2025-11-177.11%
2025-11-146.97%
2025-11-136.88%
2025-11-126.96%
2025-11-117.04%
2025-11-107.22%
2025-11-077.30%
2025-11-067.29%
2025-11-057.32%
2025-11-047.29%
2025-11-037.19%
2025-10-317.10%
2025-10-307.10%
2025-10-297.06%
2025-10-287.05%
2025-10-275.34%
2025-10-245.26%
2025-10-235.28%
2025-10-225.33%
2025-10-215.31%
2025-10-205.47%
2025-10-175.67%
2025-10-165.64%
2025-10-155.71%
2025-10-145.67%
2025-10-135.69%
2025-10-105.85%
2025-10-095.72%
2025-10-085.78%
2025-10-075.78%
2025-10-065.66%
2025-10-035.61%
2025-10-025.68%
2025-10-015.69%
2025-09-306.11%
2025-09-296.42%
2025-09-266.46%
2025-09-256.57%
2025-09-246.40%
2025-09-236.22%
2025-09-226.18%
2025-09-196.20%
2025-09-186.10%
2025-09-176.22%
2025-09-166.21%
2025-09-156.24%
2025-09-126.20%
2025-09-116.09%
2025-09-106.31%
2025-09-096.12%
2025-09-086.18%
2025-09-056.18%
2025-09-046.31%
2025-09-036.29%
2025-09-026.32%
2025-08-296.08%
2025-08-286.15%
2025-08-276.15%
2025-08-266.18%
2025-08-256.17%
2025-08-226.07%
2025-08-216.26%
2025-08-206.04%
2025-08-196.04%
2025-08-186.03%
2025-08-156.07%
2025-08-146.13%
2025-08-136.10%
2025-08-126.24%
2025-08-116.44%
2025-08-086.45%
2025-08-076.49%
2025-08-066.54%
2025-08-056.31%
2025-08-046.35%
2025-08-016.36%
2025-07-316.24%
2025-07-306.06%
2025-07-295.97%
2025-07-285.87%
2025-07-255.83%
2025-07-245.78%
2025-07-235.97%
2025-07-226.19%
2025-07-217.67%
2025-07-187.59%
2025-07-177.47%
2025-07-167.69%
2025-07-157.73%
2025-07-147.62%
2025-07-117.49%
2025-07-107.36%
2025-07-097.52%
2025-07-087.41%
2025-07-077.51%
2025-07-037.42%
2025-07-027.41%
2025-07-017.50%
2025-06-307.74%
2025-06-277.74%
2025-06-267.71%
2025-06-257.68%
2025-06-247.69%
2025-06-237.86%
2025-06-207.88%
2025-06-187.89%
2025-06-177.91%
2025-06-167.66%
2025-06-137.77%
2025-06-127.66%
2025-06-117.67%
2025-06-107.63%
2025-06-097.91%
2025-06-068.01%
2025-06-058.27%
2025-06-048.24%
2025-06-038.54%
2025-06-028.76%
2025-05-308.69%
2025-05-298.64%

Showing the most recent 260 of 3,292 data points. The chart above shows the full history.

Related Metrics

Free Cash Flow CAGREarnings YieldDividend YieldP/FCF RatioAll Metrics

About IQVIA Holdings Inc.

IQVIA Holdings Inc. is a premier global provider of sophisticated analytical insights, advanced technology solutions, and comprehensive clinical research services, catering to the life sciences industry across the Americas, Europe, Africa, and Asia-Pacific. The company's operations are structured into three key divisions: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment provides a suite of cloud-native applications, complete with implementation services, and offers real-world data solutions designed to empower life sciences and healthcare providers in generating and disseminating evidence crucial for informed decision-making and improving patient outcomes. This division also delivers strategic and operational consulting, including advanced analytics support and outsourcing of commercial processes. Furthermore, it supplies country-level performance metrics detailing pharmaceutical sales, prescribing trends, medical treatments, and promotional activities across diverse channels like retail, hospital, and mail order, with data granularity extending to regional, postal code, and individual prescriber levels. Focusing on clinical trials, the Research & Development Solutions segment offers project management, clinical monitoring, broader clinical trial support, virtual trial capabilities, and strategic planning and design services. It also manages an extensive network of laboratory services, encompassing central, genomic, bioanalytical, ADME, discovery, vaccine, and biomarker analyses. The Contract Sales & Medical Solutions segment is responsible for engaging healthcare professionals and patients, alongside providing scientific strategy and medical affairs support. IQVIA's diverse clientele includes pharmaceutical, biotechnology, medical device and diagnostic, and consumer health companies. The company maintains a strategic collaboration with HealthCore, Inc. Founded in 1982, the firm was formerly known as Quintiles IMS Holdings, Inc. before rebranding as IQVIA Holdings Inc. in November 2017. Its headquarters are located in Durham, North Carolina.

Durham, NC
89,000 employees
www.iqvia.com
Healthcare / Medical - Diagnostics & Research
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Ari Bousbib
View full financials